• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    GE HealthCare to showcase AI and digital leadership at HIMSS 2026

    3/5/26 9:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care
    Get the next $GEHC alert in real time by email
    • Booth #2525 will highlight the company's AI-powered, cloud-first and software solutions intended to help teams access data and insights more efficiently

    GE HealthCare (NASDAQ:GEHC) will showcase innovations moving healthcare forward at the Health Information and Management Systems Society (HIMSS) Global Health Conference & Exhibition 2026 in Las Vegas from March 9-12, 2026. This year, GE HealthCare will spotlight meaningful technology transforming the way healthcare professionals approach patient care, from imaging operations and fleet management to enterprise solutions, ultrasound, and patient care technologies.

    The healthcare industry continues to confront worsening workforce gaps with projections showing multi‑specialty shortages through 2038 and demand projected to outpace supply in multiple health professions, placing sustained pressure on health systems to deliver care more efficiently.i To address today's challenges and support clinicians tomorrow, GE HealthCare solutions are designed to reduce clinical and operational complexities and help providers quickly turn data into insights to help streamline workflows.

    "The future of healthcare depends on how effectively we remove complexity and empower clinicians," said Scott Miller, CEO, Solutions for Enterprise Imaging (SEI), GE HealthCare. "By anticipating what healthcare teams need next, we're accelerating cloud and AI‑enabled solutions that help them work smarter, make faster, better‑informed decisions, and deliver more connected, accessible care."

    GE HealthCare continues to lead the industry in artificial intelligence (AI) innovation, topping a U.S. Food and Drug Administration list of AI-enabled medical device authorizations, with 115 authorizations to date.ii At HIMSS 2026, GE HealthCare will exhibit several solutions pushing forward the boundaries of innovation.

    GE HealthCare is continuing to work across the industry to enable real-time data exchange between medical devices by joining the Health Level Seven® International (HL7®) Caliper FHIR® Accelerator as a founding member. Caliper is an implementation community focused on improving how data from medical and personal health devices is exchanged, integrated, and used across healthcare systems. The coalition's work will enable consistent integration of high‑fidelity device data into EHRs, analytics, and AI‑enabled applications to better support clinical decision‑making and care delivery across settings and devices.

    Key innovations to be showcased at HIMSS 2026:

    • CareIntellect™ for Perinataliii, is a cloud-first application that helps deliver clear, actionable insights designed to help clinicians access data efficiently, supporting time management at the point of care. Designed for native EMR accessibility, CareIntellect for Perinatal supports clinicians by integrating high fidelity monitor data with information from disparate data sources on a single screen, to support clinicians when monitoring status, annotating clinical events, searching historical data, and remotely monitoring. The application is part of the CareIntellect family of applications, which GE HealthCare will also be showcasing.
    • Command Center is AI-enabled software that helps hospitals and health systems manage patient flow, streamline operations, and make data-driven decisions in real-time. Used by nearly 500 hospitals and medical facilities globally, Command Center is a comprehensive, customizable solution supporting care management at every stage, from daily patient care and staff onboarding to cross-department coordination and proactive issue resolution across the hospital system.
    • Genesis™ Radiology Workspaceiv is a next-generation solution designed to transform radiology workflows, unify the user experience, and empower radiologists with great efficiency and precision. At the center of this innovation is Genesis™ View, a powerful new viewer designed to be a fast diagnostic, zero-footprint viewer – streamlining radiology workflows with the intent to enhance patient care while being fully accessible from any location.
    • Imaging 360 unlocks the full potential of imaging operations. Powered by AI, this solution delivers a unified view that helps streamline radiology fleet management, connect staff remotelyv, optimize staff allocation and support consistent quality of care.
    • Verisound™ Digital and AI Ultrasound Solutions, a portfolio of connectivity, collaboration, and AI-driven tools—designed to enhance efficiency and consistency in imaging, reduce scan and read times, improve reproducibility, and enable collaboration across care teams.
      • Verisound Collab is a dynamic collaboration hub driving real-time mentoring and engagement between peers and experts, before, during, and after an ultrasound exam to share expertise, provide support during complex exams, and elevate care delivery.vi
      • Verisound Fleet empowers clinical and healthcare technology teams to remotely view, back up, and deploy device configurations and manage probes.
      • ViewPoint™ is an ultrasound workflow solution built for scalability, reliability and interoperability aiming to solve challenges that stem from complex and expanding operations. The solution integrates advanced automation technology to create reports with findings, provide access to patient scan data from anywhere and simplify IT administration and maintenance.
    • Vscan Air™ Enterprise Solutions, suite of digital tools for Vscan Air, help address workflow challenges, offer improved security and privacy while improving the ability to simplify operations and control fleet of handheld ultrasound systems.

    GE HealthCare activities at HIMSS 2026:

    • Tuesday, March 10
      • Navigating digital transformation in healthcare IT — Cloud, AI and the data journey (12:30 PM PT, Casanova 503)
    • Wednesday, March 11
      • Putting Clinicians First – Oregon Health & Science University's (OHSU) enterprise framework for scaling handheld ultrasound (12:30 PM PT, Casanova 601)
        • Ankit Goyal, BCA, MCA, Senior Global Product Manager, GE HealthCare
        • Yonathan Teklehaimanot, MSc, CCE, CBET, Director, Clinical Technology Services, OHSU
      • Shaping the future of healthcare IT (4:00 PM PT, Booth #2525)
        • Hear from Scott Miller, CEO of SEI at GE HealthCare, who will share our vision of cloud and AI-enabled innovations helping transform what's possible in healthcare

    About GE HealthCare Technologies Inc.

    GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world's most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.

    GE HealthCare is proud to be among 2026 Fortune World's Most Admired Companies™.

    Follow us on LinkedIn, Facebook, Instagram, or visit our website for our latest news and perspectives.

     

    i Health Resources and Services Administration (HRSA) National Center for Health Workforce Analysis (NCHWA) Report: Health Workforce Projections, 2023–2038. https://data.hrsa.gov/topics/health-workforce/nchwa/workforce-projections.

    ii U.S. Food and Drug Administration. "Artificial Intelligence-Enabled Medical Devices." https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices.

    iiiCareIntellect Perinatal formerly Mural Perinatal Surveillance, a 510(k)-cleared device in the U.S. is the product name. CareIntellect for Perinatal may appear in descriptive content. Not all features and functionality are available in all markets. Product configurations are subject to change without notice. Availability is dependent on regional regulatory authorizations.

    iv Genesis Radiology Workspace consists of Genesis View, Workflow Manager, Enterprise Archive, App Orchestrator. Genesis View is not available for sale in the United States. This product cannot be placed on the market or put into service until it has been made to comply with CE marking. Genesis Radiology Workspace is not yet commercially available for USA and UK.

    v Remote scanning, training and collaboration can be fulfilled by either nCommand™ Lite by IONIC Health or Digital Expert Access with Remote Scanning for MR by GE HealthCare. Consult your sales representative for availabilities in your region.

    viNot for diagnostic use

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260305957950/en/

    GE HealthCare Media Contact:

    Julie Allison

    Senior Communications Manager

    M +1 347 327 0836

    [email protected]

    Get the next $GEHC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GEHC

    DatePrice TargetRatingAnalyst
    1/15/2026$77.00Neutral → Sell
    UBS
    10/13/2025$86.00Equal Weight
    Barclays
    10/7/2025$83.00Buy → Neutral
    Citigroup
    5/5/2025$73.00Sell → Neutral
    UBS
    3/11/2025$85.00 → $100.00Neutral → Buy
    Goldman
    1/8/2025$95.00 → $103.00Hold → Buy
    Jefferies
    9/26/2024$84.00 → $74.00Neutral → Sell
    UBS
    9/18/2024$100.00Neutral → Buy
    BTIG Research
    More analyst ratings

    $GEHC
    SEC Filings

    View All

    SEC Form DEFA14A filed by GE HealthCare Technologies Inc.

    DEFA14A - GE HealthCare Technologies Inc. (0001932393) (Filer)

    3/19/26 7:03:57 AM ET
    $GEHC
    Medical Electronics
    Health Care

    SEC Form DEF 14A filed by GE HealthCare Technologies Inc.

    DEF 14A - GE HealthCare Technologies Inc. (0001932393) (Filer)

    3/19/26 7:02:54 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare Technologies Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - GE HealthCare Technologies Inc. (0001932393) (Filer)

    3/17/26 9:14:16 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lobo Kevin was granted 777 shares (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    3/17/26 4:08:18 PM ET
    $GEHC
    Medical Electronics
    Health Care

    SEC Form 3 filed by new insider Lobo Kevin

    3 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    3/17/26 4:06:05 PM ET
    $GEHC
    Medical Electronics
    Health Care

    CEO, Patient Care Solutions Bankes Jeannette was granted 6,861 shares, increasing direct ownership by 19% to 43,892 units (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    3/4/26 4:27:18 PM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GE HealthCare to showcase comprehensive cardiology portfolio at ACC.26, including its latest AI-enabled imaging technologies, advanced software solutions, and key collaborations

    The company will highlight the newly U.S. FDA 510(k) cleared Photonova Spectra photon-counting CT system, ReadyFix fleet management solution enabled to work with MAC VU360 resting ECG workstations, and a new collaboration to advance interventional cardiology At ACC.26, GE HealthCare (NASDAQ:GEHC) will showcase some of its boldest ideas yet that support clinicians across the cardiology care pathway - from diagnosis to treatment to procedural guidance and monitoring. Its latest cardiology innovations, featuring advancements within diagnostic cardiology, CT, image guiding solutions, ultrasound, cloud, and software solutions, are helping clinicians deliver critical precision care throughout

    3/25/26 9:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare's Photonova Spectra photon-counting CT receives FDA clearance

    FDA clearance quickly follows Photonova Spectra's debut at the Radiological Society of North America (RSNA) 2025 Annual Meeting, marking rapid momentum for GE HealthCare's innovative photon-counting CT technology Photonova Spectra introduces the next generation of spectral photon-counting CT technology with 8‑bin energy resolution, powered by GE HealthCare's proprietary Deep Silicon detector technology and a one‑scan universal workflow designed to boost efficiency and reduce complexity across a wide range of CT exams Photonova Spectra is a result of the company's $5.1 billion innovation investment, leading to a wave of transformational products across the portfolio which combined are

    3/23/26 9:59:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare completes Intelerad acquisition – accelerating shift to cloud-first enterprise solutions to deliver precision care

    Expands GE HealthCare's enterprise imaging footprint by delivering comprehensive, end‑to‑end solutions across ambulatory, teleradiology, and hospital care settings Advances GE HealthCare's D3 strategy by accelerating the development of disease‑focused smart devices and solutions enabled by digital (cloud and software) and artificial intelligence (AI) capabilities Enhances a fully connected, cloud‑first imaging ecosystem with an expanded GE HealthCare portfolio of AI, digital tools, and SaaS offerings designed to improve clinical operations Tuck‑in acquisition expected to strengthen the Imaging portfolio, increase recurring revenue mix, and support sustainable top‑line growth and p

    3/18/26 4:00:00 PM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GE HealthCare downgraded by UBS with a new price target

    UBS downgraded GE HealthCare from Neutral to Sell and set a new price target of $77.00

    1/15/26 8:32:16 AM ET
    $GEHC
    Medical Electronics
    Health Care

    Barclays initiated coverage on GE HealthCare with a new price target

    Barclays initiated coverage of GE HealthCare with a rating of Equal Weight and set a new price target of $86.00

    10/13/25 8:53:16 AM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare downgraded by Citigroup with a new price target

    Citigroup downgraded GE HealthCare from Buy to Neutral and set a new price target of $83.00

    10/7/25 8:57:17 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Jimenez Frank R bought $100,624 worth of shares (1,315 units at $76.52), increasing direct ownership by 2% to 75,796 units (SEC Form 4)

    4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)

    5/2/24 6:00:38 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Leadership Updates

    Live Leadership Updates

    View All

    GE HealthCare appoints medtech leader Kevin Lobo to Board of Directors

    GE HealthCare (NASDAQ:GEHC) announced today the appointment of Kevin A. Lobo, Chair and Chief Executive Officer of Stryker Corporation (NYSE:SYK), to its Board of Directors effective March 13. Mr. Lobo brings more than 25 years of medical technology, operational, and financial leadership experience. His clinical expertise and track record of driving innovation and scaling global businesses make him well qualified to contribute to GE HealthCare's strategic priorities. "Kevin is a seasoned healthcare executive with a deep understanding of the medical technology landscape. His knowledge and insight will further strengthen our Board as we continue to build a more personalized, connected and s

    3/17/26 9:00:00 AM ET
    $GEHC
    $SYK
    Medical Electronics
    Health Care
    Medical/Dental Instruments

    PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer

    BOCA RATON, Fla., June 2, 2025 /PRNewswire/ -- PharmaLogic Holdings Corp. ("PharmaLogic" or "the Company"), a leading contract development and manufacturing organization (CDMO) specialized in radiopharmaceuticals, today announces the Company has appointed Etienne Montagut, currently serving as President, to the position of President and Chief Executive Officer, effective as of 1 June 2025. Mr. Montagut brings over 25 years of senior leadership experience in the pharmaceutical sector, with a solid track record of driving growth and executing strategic transformation across glob

    6/2/25 8:00:00 AM ET
    $GEHC
    $LNTH
    Medical Electronics
    Health Care
    Biotechnology: In Vitro & In Vivo Diagnostic Substances

    GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions

    GE HealthCare (NASDAQ:GEHC), a leading global healthcare solutions provider, announced the appointment of Jeannette Bankes as president and CEO, Patient Care Solutions, effective May 1, 2025. Peter Arduini, president and CEO, GE HealthCare, said, "Jeannette is a proven leader who has diverse and deep experience at publicly traded companies in the healthcare industry. We proudly welcome her to the company and are confident that she has the expertise to move Patient Care Solutions forward and deliver on our precision care strategy." Bankes brings with her three decades of global experience including product management, marketing, sales, regulatory, medical affairs, and operations and manufa

    4/9/25 9:00:00 AM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

    SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    11/12/24 12:53:28 PM ET
    $GEHC
    Medical Electronics
    Health Care

    Amendment: SEC Form SC 13G/A filed by GE HealthCare Technologies Inc.

    SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    10/22/24 4:16:16 PM ET
    $GEHC
    Medical Electronics
    Health Care

    SEC Form SC 13G/A filed by GE HealthCare Technologies Inc. (Amendment)

    SC 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)

    4/2/24 4:07:29 PM ET
    $GEHC
    Medical Electronics
    Health Care

    $GEHC
    Financials

    Live finance-specific insights

    View All

    GE HealthCare completes Intelerad acquisition – accelerating shift to cloud-first enterprise solutions to deliver precision care

    Expands GE HealthCare's enterprise imaging footprint by delivering comprehensive, end‑to‑end solutions across ambulatory, teleradiology, and hospital care settings Advances GE HealthCare's D3 strategy by accelerating the development of disease‑focused smart devices and solutions enabled by digital (cloud and software) and artificial intelligence (AI) capabilities Enhances a fully connected, cloud‑first imaging ecosystem with an expanded GE HealthCare portfolio of AI, digital tools, and SaaS offerings designed to improve clinical operations Tuck‑in acquisition expected to strengthen the Imaging portfolio, increase recurring revenue mix, and support sustainable top‑line growth and p

    3/18/26 4:00:00 PM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare announces cash dividend for first quarter of 2026

    The Board of Directors of GE HealthCare Technologies Inc. (NASDAQ:GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2026 payable on May 15, 2026, to all shareholders of record as of April 3, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world's most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patie

    2/12/26 6:11:00 PM ET
    $GEHC
    Medical Electronics
    Health Care

    GE HealthCare reports fourth quarter and full year 2025 financial results

    Company exceeds topline and earnings per share expectations; demonstrates operational resilience Fourth quarter 2025 highlights(1) Revenue growth of 7.1%, including Organic revenue growth* of 4.8%, driven primarily by the U.S. and Europe, the Middle East and Africa (EMEA) Net income margin of 10.3% and Adjusted earnings before interest and taxes (EBIT) margin* of 16.7% Diluted earnings per share (EPS) of $1.29 and Adjusted EPS* of $1.44 Cash flow from operating activities of $1.0 billion and Free cash flow* of $916 million Full year 2025 highlights(1) Revenue growth of 4.8%, including Organic revenue growth* of 3.5% Organic orders growth of 5.2% Net income margin o

    2/4/26 6:20:00 AM ET
    $GEHC
    Medical Electronics
    Health Care